MedTrace Logo

Escitalopram as a Treatment for Pain in Polyneuropathy

NCT00162968 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2007-04-24

No results posted yet for this study

Summary

Many people with polyneuropathy suffer from pain which is difficult to treat. Escitalopram is a relatively new drug used in the treatment of depression. Escitalopram's action mechanism on the brain suggests that escitalopram also may have an effect on neuropathic pain. This study will test the efficacy of escitalopram in patients with painful polyneuropathy.

Conditions

  • Pain
  • Polyneuropathies

Interventions

DRUG

escitalopram

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER

  • H. Lundbeck A/S

    collaborator INDUSTRY

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Soeren H Sindrup, MD, PhD · Odense University Hospital, Dept. of neurology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Completion
2007-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00162968 on ClinicalTrials.gov